Measuring functional impact of cognitive impairment: Validation of the Parkinson's disease cognitive functional rating scale

Parkinsonism and Related Disorders

Volumn 19, Issue 9, 2013, Pages 812-817

  Kulisevsky, Jaime ^a,b,c,d   Fernández de Bobadilla, Ramón ^a,b,c   Pagonabarraga, Javier ^a,b,d   Martínez Horta, Saül ^a,b   Campolongo, Antonia ^a,b   García Sánchez, Carmen ^a,b   Pascual Sedano, Berta ^a,b,d   Ribosa Nogué, Roser ^a,b,c   Villa Bonomo, Carolina ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Centro de Investigación en Red Enfermedades Neurodegenerativas   (Spain)

Author keywords

Parkinson's disease mild cognitive impairment; PD CFRS; PD CRS

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; PARKINSON DISEASE COGNITIVE FUNCTIONAL RATING SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; SENSITIVITY ANALYSIS; TEST RETEST RELIABILITY; VALIDATION PROCESS;

PARKINSON'S DISEASE MILD COGNITIVE IMPAIRMENT; PD-CFRS; PD-CRS;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84880839430     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.05.007     Document Type: Article

References (27)

1. Willis A.W., Schootman M., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Predictors of survival in patients with Parkinson disease. Archives of Neurology 2012, 69:601-607.
2. Aarsland D., Bronnick K., Larsen J.P., Tysnes O.B., Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009, 72:1121-1126.
3. Aarsland D., Bronnick K., Williams-Gray C., Weintraub D., Marder K., Kulisevsky J., et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010, 75:1062-1069.
4. Litvan I., Aarsland D., Adler C.H., Goldman J.G., Kulisevsky J., Mollenhauer B., et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Movement Disorders: Official Journal of the Movement Disorder Society 2011, 26:1814-1824.
5. Litvan I., Goldman J.G., Troster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines. Movement Disorders: Official Journal of the Movement Disorder Society 2012, 27:349-356.
6. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 2007, 22:1689-1707. quiz 837.
7. Kulisevsky J., Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Movement Disorders: Official Journal of the Movement Disorder Society 2009, 24:1103-1110.
8. Troster A.I. Aprecis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson's disease and a proposal of preliminary research criteria. Journal of the International Neuropsychological Society: JINS 2011, 1-14.
9. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders: Official Journal of the Movement Disorder Society 2008, 23:2129-2170.
10. Feldman H., Sauter A., Donald A., Gelinas I., Gauthier S., Torfs K., et al. The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Disease and Associated Disorders 2001, 15:89-95.
11. Kulisevsky J, Fernandez de Bobadilla R, Pagonabarraga J. The Parkinson Disease Cognitive Functional Rating Scale (PD-CFRS): a brief and specific instrument to rate the impact of pd cognitive symptoms on daily function 64th AAN annual meeting. New Orleans; 2012.
12. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992, 42:1142-1146.
13. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 2010, 25:2649-2653.
14. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta psychiatrica Scandinavica 1983, 67:361-370.
15. Llebaria G., Pagonabarraga J., Kulisevsky J., Garcia-Sanchez C., Pascual-Sedano B., Gironell A., et al. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 2008, 23:1546-1550.
16. Morris J.C. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics/IPA 1997, 9(Suppl. 1):173-176. discussion 7-8.
17. Pagonabarraga J., Gomez-Anson B., Rotger R., Llebaria G., Garcia-Sanchez C., Pascual-Sedano B., et al. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dementia and Geriatric Cognitive Disorders 2012, 34:312-318.
18. Pagonabarraga J., Kulisevsky J., Llebaria G., Garcia-Sanchez C., Pascual-Sedano B., Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 2008, 23:998-1005.
19. Fillenbaum G.G., Smyer M.A. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. Journal of Gerontology 1981, 36:428-434.
20. Josiah A.F., Gruber-Baldini A.L., Anderson K.E., Fishman P.S., Weiner W.J., Reich S.G., et al. The effects of gait impairment with and without freezing of gait in Parkinson's disease. Parkinsonism & Related Disorders 2012, 18:239-242.
21. Guy W. The clinician global severity and impression scales. ECDEU assessment manual for psychopharmacology 1976, 218-222. Superintendent of Documents, US Government Printing Office, US Department of Health, Education, and Welfare Publication, Washington, DC. W. Guy (Ed.).
22. Shulman L.M., Gruber-Baldini A.L., Anderson K.E., Fishman P.S., Reich S.G., Weiner W.J. The clinically important difference on the unified Parkinson's disease rating scale. Archives of Neurology 2010, 67:64-70.
23. Norman G.R. The relation between the minimally important difference and patient benefit. COPD 2005, 2:69-73.
24. Cohen J. Statistical power analysis for the behavioral sciences 1988, Erlbaum Associates, Hillsdale, N.J., Hove. 2nd ed.
25. Perneczky R., Pohl C., Sorg C., Hartmann J., Komossa K., Alexopoulos P., et al. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing 2006, 35:240-245.
26. Verbaan D., Marinus J., Visser M., van Rooden S.M., Stiggelbout A.M., Middelkoop H.A., et al. Cognitive impairment in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2007, 78:1182-1187.
27. Okonkwo O.C., Griffith H.R., Vance D.E., Marson D.C., Ball K.K., Wadley V.G. Awareness of functional difficulties in mild cognitive impairment: a multidomain assessment approach. Journal of the American Geriatrics Society 2009, 57:978-984.